Frontal Fibrosing Alopecia: When The Hairline Recedes

You notice the hairline sitting further back than it used to. Hairbands land differently, the forehead photographs higher, and somewhere along the way the eyebrows have thinned too without anyone quite registering when. Most women reach for the obvious explanation, which is ordinary pattern hair loss, and most of the time they are right.

Sometimes they are not. Frontal fibrosing alopecia behaves differently from pattern loss in one respect that changes everything about how urgently it should be assessed: the follicle is destroyed and replaced by scar tissue, so what has gone does not come back. Recognising it early is what determines how much hair stays, which is also why alopecia treatment starts with establishing which type of hair loss is present.

A scarring alopecia, not a pattern one

Frontal fibrosing alopecia is classified as a primary lymphocytic cicatricial alopecia and is regarded as a variant of lichen planopilaris. The condition was first described in 1994 in six post-menopausal women with progressive frontal scarring, whose scalp biopsies showed perifollicular fibrosis and lymphocytic inflammation dominated by activated T-helper cells¹. Hormonal studies in five of those patients showed no androgen abnormality, which is one reason the condition sits apart from female pattern hair loss¹.

The distinction is not academic. In alopecia areata, the immune system attacks hair follicles but leaves the follicular structure intact, which is why regrowth remains possible. In a scarring alopecia the follicular opening itself is lost to fibrous tissue, and treatment aims at holding the line instead of recovering ground.

Who it affects

Reported prevalence has been increasing worldwide since the original description, with a crude prevalence in New York City estimated at approximately 0.015 per cent². Between 83 and 95 per cent of Caucasian and Asian patients have onset after menopause, with a mean age of onset between 56 and 63 years². The assumption that it is exclusively a postmenopausal condition does not hold, though. Men are affected, typically younger at a mean of 47.3 years and frequently underdiagnosed, and in Black patients 74 per cent of cases in one series were pre-menopausal².

A multicentre review of 355 patients, 343 women and 12 men with a mean age of 61, classified 37 per cent as having severe disease³. Asian data exist as well. A Thai cohort of 58 patients found eyebrow loss in 69 per cent and facial papules in 32.8 per cent, and noted that diffuse and pseudo-fringe patterns are common in Asian patients, a presentation that can be mistaken for traction alopecia⁴.

What the early signs look like

The classic picture is a band-like recession of the fronto-temporal hairline, often with a rim of skin that looks paler and smoother than the scalp behind it. Partial or total eyebrow loss occurs in roughly 63 to 83 per cent of patients and frequently arrives earlier, sometimes before the hairline change is obvious².

Trichoscopy, which is examination of the scalp under magnification, supports the diagnosis. A systematic review of 33 studies comparing lichen planopilaris with frontal fibrosing alopecia found that active disease shows perifollicular erythema, scaling and yellow dots, while black dots, lonely hairs and loss of vellus hairs mark later stages⁵. Lonely hairs, the isolated strands left standing in an otherwise bare band, are therefore a late sign, and eyebrow loss is the more useful early clue⁵.

Overlap with pattern hair loss complicates the picture further, since the two coexist in somewhere between 16 and 57 per cent of women². Absence of the fine vellus hairs that normally soften the frontotemporal hairline is one of the features that separates them². A scalp biopsy is used where the clinical and trichoscopic picture leaves doubt.

What treatment can and cannot do

Efficacy in frontal fibrosing alopecia is judged by whether treatment slows or halts loss, not by regrowth, because the destroyed follicles are presumed permanent⁶. A review covering 270 records reported response rates of 88 per cent for intralesional corticosteroids, drawn from 204 treated patients, and 88 per cent for 5-alpha reductase inhibitors across 180 patients, these being the two most commonly used approaches⁶. Oral corticosteroids only temporarily delayed rapid loss⁶.

The multicentre series reached a similar conclusion, with 47 per cent of 111 patients treated with 5-alpha reductase inhibitors improving and 53 per cent stabilising³. Hydroxychloroquine and topical treatments are also used. These are prescription medicines whose suitability depends on assessment, medical history and monitoring, and none of them is a decision to make from an article.

The evidence base carries real limitations, including an absence of placebo-controlled trials and inconsistent outcome measures across studies⁶. What the literature does support is the case for early intervention while disease is active⁶.

When to have a hairline checked

A hairline that has moved over months instead of years, redness or scaling around the follicles at the margin, a forehead that looks smoother and paler along a distinct band, and eyebrow thinning alongside the scalp change are all reasons to have the scalp examined properly. Any of these can have other explanations, which is precisely why they need looking at rather than guessing at.

Conclusion

Hair that has been lost to scarring cannot be recovered, and that fact makes timing the single most useful thing a patient controls. At Angeline Yong Dermatology, Dr Angeline Yong examines the scalp, uses trichoscopy and, where needed, biopsy to establish what is driving hairline change before recommending anything. Book a consultation if your hairline or eyebrows have altered and you would like a clear answer about why.

References

Kossard, S. (1994). Postmenopausal frontal fibrosing alopecia: Scarring alopecia in a pattern distribution. Archives of Dermatology, 130(6), 770-774. https://doi.org/10.1001/archderm.1994.01690060100013

Porrino-Bustamante, M. L., Fernandez-Pugnaire, M. A., & Arias-Santiago, S. (2021). Frontal fibrosing alopecia: A review. Journal of Clinical Medicine, 10(9), Article 1805. https://doi.org/10.3390/jcm10091805

Vano-Galvan, S., Molina-Ruiz, A. M., Serrano-Falcon, C., Arias-Santiago, S., Rodrigues-Barata, A. R., Garnacho-Saucedo, G., Martorell-Calatayud, A., Fernandez-Crehuet, P., Grimalt, R., Aranegui, B., Grillo, E., Diaz-Ley, B., Salido, R., Perez-Gala, S., Serrano, S., Moreno, J. C., Jaen, P., & Camacho, F. M. (2014). Frontal fibrosing alopecia: A multicenter review of 355 patients. Journal of the American Academy of Dermatology, 70(4), 670-678. https://doi.org/10.1016/j.jaad.2013.12.003

Panchaprateep, R., Ruxrungtham, P., Chancheewa, B., & Asawanonda, P. (2020). Clinical characteristics, trichoscopy, histopathology and treatment outcomes of frontal fibrosing alopecia in an Asian population: A retro-prospective cohort study. The Journal of Dermatology, 47(11), 1301-1311. https://doi.org/10.1111/1346-8138.15517

Gowda, S. K., Errichetti, E., Behera, B., & Thakur, V. (2025). Trichoscopic features of lichen planopilaris versus frontal fibrosing alopecia: A systematic review. Dermatology Practical & Conceptual, 15(1), Article 4481. https://doi.org/10.5826/dpc.1501a4481

Ho, A., & Shapiro, J. (2019). Medical therapy for frontal fibrosing alopecia: A review and clinical approach. Journal of the American Academy of Dermatology, 81(2), 568-580. https://doi.org/10.1016/j.jaad.2019.03.079

Use of this website signifies your agreement to The Terms of Use & Privacy Policy

Terms of Use

You are deemed to have entered into an agreement with Angeline Yong Dermatology and to have agreed to be bound by the terms set out below by accessing ayd.com.sg (“the Sites”) or by otherwise accessing any content found on this web site. By accessing or using the Site, you acknowledge that you have read, understood, and agreed, without limitation or qualification, to be bound by these Terms & Conditions. The Site is owned and operated by Angeline Yong Dermatology.

Intellectual Property Protection
Use of Angeline Yong Dermatology Content
Changes to the Site
Privacy Policy
No Warranty, Disclaimer of Liability and Indemnity
Force Majeure
Miscellaneous
Governing Law and Jurisdiction

Intellectual Property Protection

The contents and design of the Site and any material e-mailed to you or otherwise supplied to you in conjunction with the Site (such contents, design and materials being collectively referred to as the “Angeline Yong Dermatology Content”, are copyright of Angeline Yong Dermatology. You may not use or reproduce or allow anyone to use or reproduce any trademarks (such as ” Angeline Yong Dermatology” name and logo or other trade names appearing on the Site) for any reason without written permission from Angeline Yong Dermatology. The software, which operates the Site, is proprietary software and you may not use it except as expressly allowed under these Terms. You may not copy, modify, reverse engineer or otherwise interfere with the software.

Use of Angeline Yong Dermatology Content

You may retrieve and display the Angeline Yong Dermatology Content on a computer screen or mobile telephone, print individual pages on paper (but not photocopy them) and store such pages in electronic form for your personal, non-commercial use. You may not save or post any of the Content on blogs, Facebook, and other websites that allows viewing by the general public without written permission from Angeline Yong Dermatology. Except as expressly set out above, you may not reproduce, modify or in any way commercially exploit any of the Angeline Yong Dermatology Content.

Changes to the Site

Angeline Yong Dermatology reserves the right to change, modify, suspend, add or remove portions of the Angeline Yong Dermatology Content available on the Site at any time and to restrict the use and accessibility of the Site in its discretion and without prior notification.

Privacy Policy

The information that you provide about yourself and your company to Angeline Yong Dermatology will only be used in accordance with Angeline Yong Dermatology’s Privacy Policy Statement. We will:

retain your information only for as long as there is a business need
take reasonable steps to ensure that the information is accurate, adequate, relevant and up to date.
update or correct your information held by us whenever necessary
take appropriate measures to prevent and minimize risks of unauthorised access to the information

We may use your personal information, such as your name and contact details, for the following purposes:

to perform the services that you have requested, which may involve contacting you by telephone, mobile phone, fax machine, post or email, including sending you electronic direct mailers.
to allow us to promote our products, events and activities.

No Warranty, Disclaimer of Liability and Indemnity

Whilst every effort has been made to ensure the high quality and accuracy of the Site, Angeline Yong Dermatology makes no warranty, express or implied, concerning the Angeline Yong Dermatology Content, the Site, software or products or services available through the Site (the “Site Services”), which are provided “as is”. Angeline Yong Dermatology expressly disclaims all warranties, including but not limited to warranties of fitness for a particular purpose and warranties of merchantability. In no event will Angeline Yong Dermatology, its affiliates or other suppliers be liable for direct, special, incidental, or consequential damages (including, without limitation, damages for loss of business profits, business interruption, loss of business information or other pecuniary loss) arising directly or indirectly from the use of (or failure to use) or reliance on the Site Services, even if Angeline Yong Dermatology and its affiliates has been advised of the possibility that such damages may arise.

Angeline Yong Dermatology does not guarantee the accuracy, content, or timeliness of the Site Services or that they or related systems are free from viruses or other contaminating or destructive properties. Angeline Yong Dermatology accepts no responsibility for the content on any site to which a hypertext link from this site exists. The links are provided “as is” with no warranty, express or implied for the information provided within them.

Upon accessing to this Site, you agree to indemnify and hold harmless Angeline Yong Dermatology and its affiliates from any claims and expenses, including reasonable legal fees, related to any breach of these Terms by you or your use of any Site Services.

Force Majeure

Angeline Yong Dermatology and its affiliates will not be liable or deemed to be in default for any delay or failure in performance or interruption of the delivery of the Angeline Yong Dermatology Content resulting directly or indirectly from any cause or circumstance beyond its or their reasonable control, including but not limited to failure of electronic or mechanical equipment or communication lines, telephone or other interconnect problems, computer viruses, unauthorized access, theft, operator errors, severe weather, earthquakes or natural disasters, strikes or other labour problems, wars, or government restrictions.

Miscellaneous

Changes to these Terms. Angeline Yong Dermatology may, in its discretion, change these Terms (including those relating to your use of Site and/or the Angeline Yong Dermatology Content. When Terms are changed, Angeline Yong Dermatology will notify you by email or by publishing details of those changes by including them in these Terms. If you use the Site after Angeline Yong Dermatology has published or notified you of the changes, you are agreeing now to be bound by those changes. If you do not agree to be bound by those changes, you should not use the Site any further after they are published. Access to certain areas of the Angeline Yong Dermatology Content may be subject to additional terms and conditions.

Advertising, Third Party Content and other Web Sites. Parts of the Site may contain advertising or other third-party content. Advertisers and other content providers are responsible for ensuring that material submitted for inclusion on the Site complies with international and national law. Angeline Yong Dermatology is not responsible for any third-party content or error, omission or inaccuracy in any advertising material. The Site may contain links to other web sites. Angeline Yong Dermatology is not responsible for the availability of these web sites or their contents.

Assignment of Agreement. This agreement is personal to you and your rights and obligations under these Terms may not be assigned, sub-licensed or otherwise transferred. This agreement may be assigned to a third party by Angeline Yong Dermatology and its affiliates.

Non-Waiver. No delay or omission on the part of either party in requiring performance by the other party of its obligations will operate as a waiver of any right.

Notices. Notices to Angeline Yong Dermatology and its affiliates must be given in writing by letter.

Severability/Survival/Statute of Limitations. If any provision of these Terms is invalid or unenforceable, such will not render all the Terms unenforceable or invalid but rather the Terms will be read and construed as if the invalid or unenforceable provision(s) are not contained therein. Any cause of action of yours with respect to these Terms must be filed in a court of competent jurisdiction in Singapore, within one year after the cause of action has arisen, or such cause will be barred, invalid, and void.

Whole Agreement. Save as expressly referred to herein, any representation, warranty, term or condition not expressly set out in these Terms shall not apply.

Headings. Headings in these Terms are for convenience only and have no legal meaning or effect.

Governing Law and Jurisdiction

These Terms shall be governed by, and construed in accordance with the Laws of the Republic of Singapore. The parties irrevocably agree that the courts of Singapore shall (subject to the paragraph below) have exclusive jurisdiction to settle any dispute which may arise out of, under, or in connection with these Terms or the legal relationship established by them, and for those purposes irrevocably submit all disputes to the jurisdiction of Singapore courts. For the exclusive benefit of Angeline Yong Dermatology and its affiliates, Angeline Yong Dermatology and its affiliates shall retain the right to bring proceedings as to the substance of the matter in the courts of the country of your residence or, where these Terms are entered into in the course of your trade or profession, the country of your principal place of business.

Media.

Frontal Fibrosing Alopecia: When The Hairline Recedes